Delivery Order SPE2DB22D1106-SPE2DB25FFGA5
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,223.04 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of VIMPAT 10 mg/ml Solution in 200ml quantities. This firm fixed-price delivery order, which is non-set-aside and competitively awarded, will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. VIMPAT (lacosamide) is a prescription anticonvulsant medication used in the treatment of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VIMPAT 10 mg/ml Solution 200ml, with a ceiling value of $1,136.96 under a firm fixed price contract type. The award was executed on July 30, 2025, with an ultimate completion date of July 31, 2025. This non-set-aside competitive award is being performed at the contractor's facility in Conshohocken, Pennsylvania. VIMPAT (lacosamide) is an anticonvulsant medication used in the treatment of neurological...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of VIMPAT 200 MG tablets in a quantity of 60 units, with a contract ceiling value of $1,089.82. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award through open competition. The contract has an ultimate completion date of July 28, 2025, and AmerisourceBergen will perform this work from its corporate office location in...
- The Defense Logistics Agency awarded a $1,020.96 delivery order to AmerisourceBergen Drug Corp for 60 tablets of VIMPAT 100 mg on August 7, 2025, with a completion date of August 8, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation. VIMPAT (lacosamide) is a prescription medication used in the treatment of partial-onset seizures and is being supplied to support federal medical procurement needs. The vendor, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of VIMPAT 100 mg at a ceiling value of $1,089.84 under a firm fixed price contract type. This award, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a non-set-aside competitive procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger...
- The Defense Logistics Agency awarded a $1,455.99 delivery order to AmerisourceBergen Drug Corp on August 1, 2025, for VIMPAT 10 mg/mL Solution in 200 mL quantities. This firm fixed price order, with an ultimate completion date of August 4, 2025, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract was awarded without a set-aside designation through competitive procurement, and performance will occur at the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,670.96 to AmerisourceBergen Drug Corp for VIMPAT 10 mg/mL solution (200 mL), a pharmaceutical product used in neurological treatment. This competitively awarded, firm fixed-price delivery order was issued on August 15, 2025, with an ultimate completion date of August 18, 2025. The award carries no set-aside designation and is being fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of VIMPAT 100 mg tablets (60-count units) valued at $2,048.51. This firm fixed-price delivery order, which is expected to be completed by August 14, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was made...
- The Defense Logistics Agency awarded a delivery order valued at $1,256.32 to AmerisourceBergen Drug Corp for VIMPAT 10 mg/ml solution in 200ml quantities. This non-competitive delivery order, issued on August 14, 2025, represents a firm fixed-price procurement executed under a child contract arrangement with an ultimate completion date of August 15, 2025. The pharmaceutical product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $971.79 firm fixed price delivery order to Amerisourcebergen Drug Corporation for VIMPAT 10 MG/ML solution in 200ML bottles. The prime contractor, Amerisourcebergen Drug Corporation, will deliver the pharmaceutical products from its facility in Conshohocken, Pennsylvania to fulfill requirements under the order. The order was awarded on August 16, 2023 with performance period concluding on August 17, 2023. No set aside designation or subcontractors were...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB25FFGA5Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of VIMPAT 10 mg/mL solution in 200 mL quantities, valued at $1,844.01. This is a firm fixed-price delivery order with an ultimate completion date of September 2, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating it was competitively awarded. VIMPAT (lacosamide) is an antiepileptic medication used in military healthcare systems to manage seizure disorders among service members and beneficiaries. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement valued through December 2026 that enables the company to supply pharmaceuticals and medical supplies globally to support military healthcare programs. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp serves the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through this comprehensive contract vehicle, which encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/29/25 |